CRIMSON: Considering Risk and Benefits in Multiple Sclerosis Treatment Selection

The Multiple Sclerosis Society

Home

home-page

With the increasing number of treatments available to people with MS, choosing the right treatment has never been a more difficult decision to make.

CRIMSON is a  two-year research project (2016-2018) funded by the MS Society and led by Dr Ana Manzano from the Centre for Health, Technologies & Social Practice, University of Leeds. This study aims to improve our understanding of how people with multiple sclerosis weigh up the pros and cons of treatments. It will also help health care professionals to take those preferences into account when helping someone to choose a treatment, in the context of their individual circumstances.

© Copyright Leeds 2017